Australia markets closed

Zealand Pharma A/S (0NZU.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
937.50+5.25 (+0.56%)
As of 09:05AM BST. Market open.
Currency in DKK

Valuation measures4

Market cap (intra-day) 65.32B
Enterprise value 63.70B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)158.09
Price/book (mrq)22.92
Enterprise value/revenue 185.03
Enterprise value/EBITDA -39.09

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 3286.60%
S&P500 52-week change 323.28%
52-week high 3969.00
52-week low 3212.20
50-day moving average 3717.58
200-day moving average 3526.46

Share statistics

Avg vol (3-month) 354.94k
Avg vol (10-day) 340.11k
Shares outstanding 558.3M
Implied shares outstanding 659.62M
Float 844.59M
% held by insiders 10.18%
% held by institutions 156.80%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 June 2023


Profit margin 0.00%
Operating margin (ttm)-831.21%

Management effectiveness

Return on assets (ttm)-28.81%
Return on equity (ttm)-88.34%

Income statement

Revenue (ttm)91.67M
Revenue per share (ttm)1.77
Quarterly revenue growth (yoy)-59.00%
Gross profit (ttm)103.99M
EBITDA -640.09M
Net income avi to common (ttm)-986.08M
Diluted EPS (ttm)-15.13
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.69B
Total cash per share (mrq)29.05
Total debt (mrq)116.86M
Total debt/equity (mrq)6.76%
Current ratio (mrq)9.17
Book value per share (mrq)29.65

Cash flow statement

Operating cash flow (ttm)-770.77M
Levered free cash flow (ttm)-435.44M